Some conservative Indiana lawmakers who want to stymie planned COVID-19 vaccine mandates for private employers are facing skepticism from their own Republican leaders and the state’s largest business group.
The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month.
More than 247,000 Hoosiers have already gotten vaccine boosters, after a daily increase of 5,690.
Federal regulators will meet over the next two weeks to weigh the benefits of giving shots to children, after lengthy studies meant to ensure the safety of the vaccines.
An obscure White House office is expected to give the green light any day to the rule’s fine print detailing how and when companies will have to require their employees to be vaccinated or undergo weekly testing.
Statewide hospitalizations due to COVID-19 decreased from 1,576 on Sunday to 1,551 on Monday, their lowest number since Aug. 16.
Preliminary results of a U.S. government-sponsored trial found that mixing coronavirus vaccines produces as much or more antibodies as using the same shot as a booster.
More than a year and a half after the coronavirus pandemic upended daily life, the supply of basic goods at U.S. grocery stores and restaurants is once again falling victim to intermittent shortages and delays.
More COVID-19 booster shots may be on the way—but when it’s your turn, you’ll get an extra dose of the original vaccine. And that has some experts wondering if the booster campaign is a bit of a missed opportunity to target delta and its likely descendants.
Residents who live in 23 targeted ZIP codes with high rates of COVID-19 and lower-than-average rates of vaccination can get free, rapid, at-home testing kits that health officials hope will reduce the spread of the deadly virus.
More than 235,000 Hoosiers have already gotten COVID-19 vaccine boosters, with a weekend increase of nearly 15,000.
At issue is $350 billion for states, counties and cities that was part of the massive COVID-19 relief bill signed in March. Under rules developed by the U.S. Treasury Department, some governments have more flexibility than others to spend their share of the money as they want.
U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.
According to the state health department’s latest breakthrough statistics, nearly 500 people in Indiana have died of COVID-19 despite being fully vaccinated.
U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson’s single-shot COVID-19 vaccine and when—and whether using a competing brand for the second dose might provide better protection.
The panel of outside advisers to the FDA voted unanimously to recommend a booster shot for seniors, as well as younger adults with other health problems, jobs or living situations that put them at increased risk from COVID-19.
The International Monetary Fund called Thursday for greater efforts from wealthy nations to boost COVID vaccination rates in poorer countries, while also urging the Federal Reserve and other central banks to respond quickly if current inflation pressures prove not to be transitory.
Statewide hospitalizations due to COVID-19 decreased from 1,708 on Tuesday to 1,634 on Wednesday, the lowest number since Aug. 17.
FDA scientists didn’t reach a firm conclusion about whether there’s enough evidence for J&J boosters, citing shortcomings with the company’s data and little information on protection against the extra-contagious delta variant.
Statewide hospitalizations due to COVID-19 decreased from 1,729 on Monday to 1,708 on Tuesday. More than 21% of Indiana’s intensive care unit beds are occupied by COVID patients.
